Syöpätautien klinikka

Julkaisut 2008
Publications 2008

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Syrjänen K et al. Age at menarche is not an independent risk factor for high-risk human papillomavirus infections and cervical intraepithelial neoplasia.
2 Abdalla F et al. Nuclear morphometry in FNABs of breast disease in libyans.
3 Bendardaf R et al. VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.
4 Bendardaf R et al. Thymidylate synthase and microsatellite instability in colorectal cancer: Implications for disease free survival, treatment response and survival with metastases.
5 Bendardaf R et al. Oncoprotein Bcl-2 and microsatellite instability are associated with disease-free survival and treatment response in colorectal cancer.
6 Bendardaf R et al. Bcl-2 expression significantly correlates with thymidylate synthase expression in colorectal cancer patients.
7 Bernoulli J et al. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
8 Branca M et al. Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling.
9 Bubendorf L et al. Molecular Techniques.
10 Buhmeida A et al. Expression of the cell-cell adhesion molecule beta-catenin in colorectal carcinomas and their metastases.
11 Derchain SF et al. Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.
12 Elzagheid A et al. Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma.
13 Elzagheid A et al. Up-regulation of alfa-catenin is associated with increased lymph node involvement in colorectal cancer.
14 Elzagheid A et al. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
15 Giorgi C et al. Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.
16 Giuliani L et al. Detection of oncogenic DNA viruses in colorectal cancer.
17 Hammes LS et al. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.
18 Huovinen R. Rintasyöpä.
19 Jyrkkiö S. Kun syöpä ei enää parane.
20 Kalliokoski T et al. Pancreatic glucose uptake in vivo in men with newly diagnosed type 1 diabetes.
21 Kankuri-Tammilehto M. Association of p53, Ki-67, COX-2, and Her-2 expressions, as well as T-stage and histopathologic grade, with occurrence of metastases and survival in renal cell carcinoma.
22 Kauhava L et al. Lower recurrence risk through mammographic screening reduces breast cancer treatment costs.
23 Komar G et al. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.
24 Korkeila E. Syöpäkivun hoito.
25 Leppä S et al. Diffuusin suurisoluisen B-solulymfooman hoito.
26 Longatto-Filho A et al. Self-sampling for human papillomavirus (HPS) testing as cervical cancer screening option. Experience from the LAMS study.
27 Longatto-filho A, Syrjänen KJ. Citologia Cervical.
28 Majamaa H, Vihinen P. Melanooma.
29 Martinez EZ et al. Bayesian estimation of performance measures of cervical cancer screening tests in the presence of covariates and absence of a gold standard.
30 Minn H. Sädehoito.
31 Minn H et al. Imaging of tumor hypoxia to predict treatment sensitivity.
32 Mohnike K et al. (18F)-dopa positron emission tomography for preoperative localization in congenital hyperinsulinism.
33 Monsonego J et al. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
34 Monsonego J et al. Detection of human papillomavirus genotypes among high-risk women: A comparison of hybrid capture and linear array tests.
35 Nordman E. Voidaanko syöpäsairauksia ehkäistä?
36 Paatero I, Elenius K. ErbB4 and its isoforms: Patentable drug targets?
37 Paba P et al. Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways.
38 Pyrhönen S. Syövän lääkehoidot.
39 Pyrhönen S et al. Toremifene. Past, Present and Future.
40 Rama C et al. Rastreamento anterior para câncer de colo uterino em mulheres com alteracoes citológicas ou histológicas.
41 Rama CH et al. Prevalência do HPV em mulheres rastreadas para o câncer cervical.
42 Rantanen K et al. Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation.
43 Ristamäki R. Kolorektaalisyöpä.
44 Rothenberg ML et al. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study.
45 Salminen E et al. Needs of developing the skills of palliative care at the oncology ward.
46 Sarian LOZ, Syrjänen KJ. Métodos de Inspecao visual para rastreamento do cancer do colo do utero.
47 Sarkola M et al. Human papillomavirus in the placenta and umbilical cord blood.
48 Schrey AR et al. Monitoring microvascular free flaps with tissue oxygen measurement and pet.
49 Seppälä M et al. Stereotaktinen sädehoito kallon alueelle.
50 Siekkinen M et al. Quality of care experienced by Finnish cancer patients during radiotherapy.
51 Siekkinen M et al. Internet knowledge expectations by radiotherapy patients.
52 Simen-Kapeu A et al. Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection.
53 Sundvall M et al. Role of ErbB4 in breast cancer.
54 Sundvall M et al. Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms.
55 Syrjänen K. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
56 Syrjänen K. Evolución natural de las infecciones por papilomavirus humano.
57 Syrjänen K et al. Value of conventional Pap smear, liquid-based cytology, visual inspection and human papillomavirus testing as optional screening tools among Latin American women <35 and >35 years of age.
58 Syrjänen K et al. Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort.
59 Syrjänen S, Syrjänen K. The history of papillomavirus research.
60 Vihinen P et al. Diagnostic and prognostic role of matrix metalloproteases in cancer.
61 Vihinen P et al. Serum matrix metalloproteinase-8 is associated with ulceration and vascular invasion of malignant melanoma.
62 Vihinen P, Pyrhönen S. Long-term response to daily low-dose subcutaneous interferon-alfa2b in a patient with pretreated metastatic uveal melanoma in the liver and lung.
Julkaisutietokanta 7.10.2009 Publications Data Base 7.10.2009